HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S L Matheson Selected Research

3-methyl-1,2,3-triazene

3/2001Design of a chimeric 3-methyl-1,2,3-triazene with mixed receptor tyrosine kinase and DNA damaging properties: a novel tumor targeting strategy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S L Matheson Research Topics

Disease

4Schizophrenia (Dementia Praecox)
12/2017 - 05/2010
1Psychotic Disorders (Schizoaffective Disorder)
09/2011
1Hallucinations (Hallucination)
05/2010
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2001
1Neoplasms (Cancer)
03/2001

Drug/Important Bio-Agent (IBA)

1Silver Sulfadiazine (SSD)FDA LinkGeneric
12/2017
1Pharmaceutical PreparationsIBA
09/2011
1Brain-Derived Neurotrophic Factor (BDNF)IBA
09/2011
1Antipsychotic Agents (Antipsychotics)IBA
05/2010
1A-Form DNA (A-DNA)IBA
03/2001
1SMA-41IBA
03/2001
1ErbB Receptors (EGF Receptor)IBA
03/2001
13-methyl-1,2,3-triazeneIBA
03/2001
1DNA (Deoxyribonucleic Acid)IBA
03/2001
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
03/2001
1O(6)-Methylguanine-DNA MethyltransferaseIBA
03/2001
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2001

Therapy/Procedure

2Transcranial Magnetic Stimulation
09/2010 - 05/2010